 |
Researchers may have discovered a new way to effectively treat periodontitis patients.
A double-blind, placebo-controlled study of chronic periodontitis patients indicated that Lactobacillus reuteri Prodentis can improve efficacy by 53 percent.
The information appears in the online publication Journal of Clinical Periodontology. The study included 30 patients.
The goal of the study was to analyze the impact of Lactobacillus reuteri Prodentis on scaling and root planing, some of the basic treatment for chronic periodontitis patients.
At the end of the study, about 53 percent of patients with deep dental pockets supplemented by Lactobacillus reuteri Prodentis needed surgery as compared to the placebo group. When the intervention period was over, about two-thirds of the patients in the placebo group were considered at high risk for disease progression. The patients provided with the antibiotic were only at 27 percent.
There was more pocket depth reduction and attachment gain for the group supplemented with Lactobacillus reuteri Prodentis.
The results from this study indicate that Lactobacillus reuteri Prodentis could save people money and prevent them from experiencing pain.
